Shah, Ashu
Chaudhary, Sanjib http://orcid.org/0000-0001-9630-1235
Lakshmanan, Imayavaramban http://orcid.org/0000-0003-1733-2223
Aithal, Abhijit
Kisling, Sophia G. http://orcid.org/0000-0003-3287-1495
Sorrell, Claire http://orcid.org/0000-0001-9153-075X
Marimuthu, Saravanakumar
Gautam, Shailendra K.
Rauth, Sanchita
Kshirsagar, Prakash
Cox, Jesse L. http://orcid.org/0000-0002-4590-7381
Natarajan, Gopalakrishnan
Bhatia, Rakesh
Mallya, Kavita
Rachagani, Satyanarayana
Nasser, Mohd Wasim http://orcid.org/0000-0003-2070-4972
Ganti, Apar Kishor
Salgia, Ravi
Kumar, Sushil
Jain, Maneesh
Ponnusamy, Moorthy P. http://orcid.org/0000-0001-5744-193X
Batra, Surinder K.
Funding for this research was provided by:
Division of Cancer Prevention, National Cancer Institute (R01 CA263575)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01 CA256973, R01 CA228524, R01 CA273319, R01 CA247471, R01 CA273349, R01 CA210637)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Article History
Received: 14 February 2023
Accepted: 6 July 2023
First Online: 11 August 2023
Competing interests
: S.K.B. is one of the co-founders of Sanguine Diagnostics and Therapeutics, Inc. A.K.G. has served as a consultant for AstraZeneca, Jazz Pharmaceuticals, Flagship Biosciences, G1 Therapeutics, Cardinal Health, Mirati Therapeutics, Beigene Ltd, Sanofi Genzyme and Regeneron Pharmaceuticals DSMB Chair for Y-mAbs Therapeutics outside the submitted work. The other authors declare no potential conflicts of interest.